These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10468247)

  • 1. Aprotinin has direct platelet protective properties: fact or fiction?
    Shore-Lesserson L
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):379-81. PubMed ID: 10468247
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study.
    Lavee J; Savion N; Smolinsky A; Goor DA; Mohr R
    Ann Thorac Surg; 1992 Mar; 53(3):477-81. PubMed ID: 1371665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
    Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
    Basora M; Gomar C; Escolar G; Pacheco M; Fita G; Rodriguez E; Ordinas A
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
    Mohr R; Goor DA; Lusky A; Lavee J
    Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin counteracts heparin-induced inhibition of platelet contractile force.
    Carr ME; Carr SL; Roa V; McCardell KA; Greilich PE
    Thromb Res; 2002 Nov; 108(2-3):161-8. PubMed ID: 12590953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
    Flaujac C; Pouard P; Boutouyrie P; Emmerich J; Bachelot-Loza C; Lasne D
    Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery.
    Landis RC; Asimakopoulos G; Poullis M; Thompson R; Nourshargh S; Haskard DO; Taylor KM
    Heart Surg Forum; 2001; 4 Suppl 1():S35-9. PubMed ID: 11178306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of aprotinin in profoundly hypothermic circulatory arrest.
    Westaby S
    J Card Surg; 1997; 12(2 Suppl):207-13. PubMed ID: 9271747
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vitro effects of aprotinin on twelve different ACT tests.
    Jones K; Nasrallah F; Darling E; Clay N; Searles B
    J Extra Corpor Technol; 2004 Mar; 36(1):51-7. PubMed ID: 15095841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1986: Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs. Updated in 1994.
    DeAnda A; Miller DC
    Ann Thorac Surg; 1994 Mar; 57(3):778-80. PubMed ID: 7511885
    [No Abstract]   [Full Text] [Related]  

  • 12. Aprotinin administration in the pericardial cavity does not prevent platelet activation.
    Landis RC; Taylor KM
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):405-6. PubMed ID: 11479528
    [No Abstract]   [Full Text] [Related]  

  • 13. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.
    Donahue MA; Price PM
    Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antithrombotic and antiinflammatory mechanisms of action of aprotinin.
    Landis RC; Asimakopoulos G; Poullis M; Haskard DO; Taylor KM
    Ann Thorac Surg; 2001 Dec; 72(6):2169-75. PubMed ID: 11789829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastographic analysis of patients receiving aprotinin with comparisons to platelet aggregation and other assays.
    Koza MJ; Walenga JM; Khenkina YN; Sullivan HJ; Montoya A; Pifarre R
    Semin Thromb Hemost; 1995; 21 Suppl 4():80-5. PubMed ID: 8747694
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study.
    Lavee J; Raviv Z; Smolinsky A; Savion N; Varon D; Goor DA; Mohr R
    Ann Thorac Surg; 1993 Jan; 55(1):114-9. PubMed ID: 7678061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function and hypothermic cardiopulmonary bypass.
    Lisi G; Sani G; Maccherini M; Biagioli B; Toscano M
    Ann Thorac Surg; 1993 Dec; 56(6):1442-3. PubMed ID: 7505560
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the adhesion and the evolution of the blood platelets. Their reaction with cyclonamin, trans-AMCHA and a kallikrein-inhibitor through a phlebostase-test.
    Pfeifer GW; von Nathusius U; Schmidt J
    Acta Univ Carol Med Monogr; 1972; 52():107-11. PubMed ID: 4544611
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of aprotonin on platelets in vitro using whole blood flow cytometry.
    Kozek-Langenecker SA; Mohammad SF; Masaki T; Green W; Kamerath C; Cheung AK
    Anesth Analg; 2000 Jan; 90(1):12-6. PubMed ID: 10624968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.